Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $227.6K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $167.2K | SEC | |
| Buy | $248.3K | SEC | |
| Buy | $248.8K | SEC | |
| Buy | $11.6K | SEC | |
| Buy | $18.1K | SEC | |
| Buy | $7.6K | SEC | |
| Buy | $20.9K | SEC | |
| Buy | $26.8K | SEC | |
| Buy | $19.2K | SEC | |
| Buy | $24.8K | SEC | |
| Buy | $24.2K | SEC | |
| Buy | $25.3K | SEC | |
| Buy | $24.3K | SEC | |
| Buy | $23K | SEC | |
| Buy | $24.2K | SEC | |
| Buy | $253.1K | SEC | |
| Buy | $1.5B | SEC |